|
RBBP9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.162600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.016100E-02 |
| Normal-vs-Stage2 |
2.929000E-01 |
| Normal-vs-Stage3 |
9.253200E-01 |
| Normal-vs-Stage4 |
2.892000E-01 |
| Stage1-vs-Stage2 |
9.822200E-01 |
| Stage1-vs-Stage3 |
9.381600E-02 |
| Stage1-vs-Stage4 |
8.353800E-01 |
| Stage2-vs-Stage3 |
3.194800E-01 |
| Stage2-vs-Stage4 |
8.572400E-01 |
| Stage3-vs-Stage4 |
3.213600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.742980E-01 |
| Normal-vs-AfricanAmerican |
2.613000E-01 |
| Normal-vs-Asian |
4.512800E-01 |
| Caucasian-vs-AfricanAmerican |
5.729000E-01 |
| Caucasian-vs-Asian |
9.298200E-01 |
| AfricanAmerican-vs-Asian |
6.022000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.689700E-02 |
| Normal-vs-Female |
2.922200E-01 |
| Male-vs-Female |
8.811600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.287600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.210600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.876200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.676600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.265400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.145400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.443000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.460200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.603000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.823600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.013800E-01 |
| Classical-VS-Follicular |
8.484600E-01 |
| Classical-VS-Other |
2.574800E-01 |
| Classical-VS-Normal |
7.407900E-02 |
| Tall-VS-Follicular |
2.452200E-01 |
| Tall-VS-Other |
7.734400E-01 |
| Tall-VS-Normal |
8.409200E-01 |
| Follicular-VS-Other |
2.536600E-01 |
| Follicular-VS-Normal |
1.383440E-01 |
| Other-VS-Normal |
8.642200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.579010E-01 |
| Normal-vs-N1 |
5.777400E-01 |
| N0-vs-N1 |
6.329200E-01 |
|
|
